Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.493,01
-0,34%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Opthea Ltd (OPT) Opthea Ltd (OPT) Notizie

OPT

Opthea (OPT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPT
DataOraFonteTitoloSimboloCompagnia
28/05/202412:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
27/12/202312:00GlobeNewswire Inc.Opthea to Receive US$35M Commitment and Additional US$50M FundingNASDAQ:OPTOpthea Ltd
19/12/202312:00GlobeNewswire Inc.Opthea Receives A$8.8 million R&D Tax IncentiveNASDAQ:OPTOpthea Ltd
01/12/202311:30GlobeNewswire Inc.Opthea to Present at the FLORetina 2023 CongressNASDAQ:OPTOpthea Ltd
09/11/202311:30GlobeNewswire Inc.Opthea to Present at the Jefferies 2023 London Healthcare ConferenceNASDAQ:OPTOpthea Ltd
30/10/202310:30GlobeNewswire Inc.Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) ConferenceNASDAQ:OPTOpthea Ltd
27/10/202311:30GlobeNewswire Inc.Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFONASDAQ:OPTOpthea Ltd
02/10/202311:30GlobeNewswire Inc.Opthea to Participate at the 2023 Euretina CongressNASDAQ:OPTOpthea Ltd
07/09/202311:30GlobeNewswire Inc.Opthea to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:OPTOpthea Ltd
28/08/202311:30GlobeNewswire Inc.Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)NASDAQ:OPTOpthea Ltd
26/07/202312:00GlobeNewswire Inc.Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302NASDAQ:OPTOpthea Ltd
24/07/202312:00GlobeNewswire Inc.Opthea to Present at the 2023 Ophthalmology Innovation SummitNASDAQ:OPTOpthea Ltd
13/07/202312:00GlobeNewswire Inc.Opthea to Feature at the American Society of Retina Specialists 2023 Annual MeetingNASDAQ:OPTOpthea Ltd
10/07/202312:00GlobeNewswire Inc.Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical AdvisorNASDAQ:OPTOpthea Ltd
08/06/202312:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:OPTOpthea Ltd
08/06/202312:00GlobeNewswire Inc.Opthea Appoints Anshul Thakral as Non-Executive Director of the BoardNASDAQ:OPTOpthea Ltd
25/05/202314:00PR Newswire (Canada)Optiva and lifecell Named as a Nominee in TM Forum's 16th Annual Excellence AwardsNASDAQ:OPTOpthea Ltd
25/05/202312:00GlobeNewswire Inc.Opthea to Present at the Jefferies 2023 Healthcare ConferenceNASDAQ:OPTOpthea Ltd
17/05/202312:00GlobeNewswire Inc.Opthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD MarketNASDAQ:OPTOpthea Ltd
08/05/202311:30GlobeNewswire Inc.Opthea To Present at the JMP Securities Life Sciences ConferenceNASDAQ:OPTOpthea Ltd
28/04/202311:30GlobeNewswire Inc.Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQNASDAQ:OPTOpthea Ltd
07/03/202312:00GlobeNewswire Inc.Opthea Receives A$8.7 million R&D Tax IncentiveNASDAQ:OPTOpthea Ltd
06/03/202312:00GlobeNewswire Inc.Opthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare ConferenceNASDAQ:OPTOpthea Ltd
14/02/202322:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPTOpthea Ltd
13/02/202312:00GlobeNewswire Inc.Opthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis® for wet AMD Published in the Journal OphthalmologyNASDAQ:OPTOpthea Ltd
06/02/202312:00GlobeNewswire Inc.Opthea To Present at SVB Leerink Global Biopharma ConferenceNASDAQ:OPTOpthea Ltd
30/01/202312:00GlobeNewswire Inc.Opthea To Present at Sequire Biotechnology ConferenceNASDAQ:OPTOpthea Ltd
12/12/202216:08GlobeNewswire Inc.Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MDNASDAQ:OPTOpthea Ltd
06/12/202212:00GlobeNewswire Inc.Opthea to Present at the FLORetina 2022 CongressNASDAQ:OPTOpthea Ltd
10/11/202212:00GlobeNewswire Inc.Opthea to Present at Jefferies London Healthcare ConferenceNASDAQ:OPTOpthea Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPT

La tua Cronologia

USOTC
IRJHF
IR Japan (PK)
USOTC
HTCMF
Hitachi Construction Mac... (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network